Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03161704 · ClinicalTrials.gov registry record
Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 114
- Enrollment target
NCT03161704 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 114 participants.
The verdict
NCT03161704 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
This study involves the prospective collection of endometrial biopsy tissue, serum, plasma, whole blood for DNA extraction, and urine from women who will be diagnosed as having (or not having) endometriosis at the time of scheduled surgery. The investigators plan to enroll approximately 500 women to validate and optimize the use of genomic classifiers alone or in combination with serum markers (such as cytokines) as a non-surgical marker of disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2016-07-08 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03161704
The ClinicalTrials.gov registry entry for NCT03161704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03161704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03161704 about?
NCT03161704 is a clinical study titled "Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol". This study involves the prospective collection of endometrial biopsy tissue, serum, plasma, whole blood for DNA extraction, and urine from women who will be diagnosed as having (or not having) endometriosis at the time of scheduled surgery. The investigators plan to enroll approximately 500 women to...
What is the current status of trial NCT03161704?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2016-07-08. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT03161704?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.